Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Asher Chanan-Khan

Showing results (1-10 of 101) with videos related to

Pageof 11
Sort By:
Current Opinion in Oncology|January 1, 2005
Bcl-2 antisense therapy in hematologic malignanciesAsher Chanan-Khan
Blood Reviews|March 24, 2005
Bcl-2 antisense therapy in B-cell malignanciesAsher Chanan-Khan
Current Treatment Options in Oncology|July 6, 2004
Bcl-2 antisense therapy in B-cell malignant proliferative disordersAsher Chanan-Khan, Myron S Czuczman
The Lancet. Oncology|June 6, 2006
Immunomodulating drugs for chronic lymphocytic leukaemiaAsher Chanan-Khan, Carl W Porter
Current Opinion in Oncology|August 23, 2002
Radioimmunotherapy in non-Hodgkin lymphomaAsher Chanan-Khan, Myron S Czuczman
Clinical Lymphoma & Myeloma|August 2, 2006
Supportive care in multiple myelomaAsher Chanan-Khan, Kena C Miller
Best Practice & Research. Clinical Haematology|November 10, 2016
Novel therapeutic targets in Waldenstrom macroglobulinemiaAneel Paulus, Sikander Ailawadhi, Asher Chanan-Khan
Leukemia & Lymphoma|August 17, 2022
CD38 as a multifaceted immunotherapeutic target in CLLAneel Paulus, Fabio Malavasi, Asher Chanan-Khan
Clinical Advances in Hematology & Oncology : H&O|January 4, 2011
Clinical roundtable monograph. New alternatives in CLL therapy: managing adverse eventsAsher Chanan-Khan, Thomas Kipps, Stephan Stilgenbauer
Best Practice & Research. Clinical Haematology|November 10, 2016
Preclinical models of Waldenström's macroglobulinemia and drug resistanceSikander Ailawadhi, Aneel Paulus, Asher Chanan-Khan
Pageof 11

Showing results (1-10 of 101) with videos related to

Sort By:
Pageof 11
Current Opinion in Oncology|January 1, 2005
Bcl-2 antisense therapy in hematologic malignanciesAsher Chanan-Khan
Blood Reviews|March 24, 2005
Bcl-2 antisense therapy in B-cell malignanciesAsher Chanan-Khan
Current Treatment Options in Oncology|July 6, 2004
Bcl-2 antisense therapy in B-cell malignant proliferative disordersAsher Chanan-Khan, Myron S Czuczman
The Lancet. Oncology|June 6, 2006
Immunomodulating drugs for chronic lymphocytic leukaemiaAsher Chanan-Khan, Carl W Porter
Current Opinion in Oncology|August 23, 2002
Radioimmunotherapy in non-Hodgkin lymphomaAsher Chanan-Khan, Myron S Czuczman
Clinical Lymphoma & Myeloma|August 2, 2006
Supportive care in multiple myelomaAsher Chanan-Khan, Kena C Miller
Best Practice & Research. Clinical Haematology|November 10, 2016
Novel therapeutic targets in Waldenstrom macroglobulinemiaAneel Paulus, Sikander Ailawadhi, Asher Chanan-Khan
Leukemia & Lymphoma|August 17, 2022
CD38 as a multifaceted immunotherapeutic target in CLLAneel Paulus, Fabio Malavasi, Asher Chanan-Khan
Clinical Advances in Hematology & Oncology : H&O|January 4, 2011
Clinical roundtable monograph. New alternatives in CLL therapy: managing adverse eventsAsher Chanan-Khan, Thomas Kipps, Stephan Stilgenbauer
Best Practice & Research. Clinical Haematology|November 10, 2016
Preclinical models of Waldenström's macroglobulinemia and drug resistanceSikander Ailawadhi, Aneel Paulus, Asher Chanan-Khan
Pageof 11